|WHO (OMS) Pandemic Information and Announcements
January 6th, 2012, 10:52 AM
Membro del Comitato Consultivo, Editore e Direttore del Forum Italiano di FluTrackers
Join Date: Dec 2007
Location: Padua, Italy
Peer-reviewed literature - 06 January 2012 (WHO, edited): H3N2v in USA, Oseltamivir-resistant H1N1pdm09 in Australia
[Source: World Health Organization, full text: (LINK
Peer-reviewed literature - 06 January 2012
Report of human cases of swine origin influenza viruses in the United States of America
The Centers for Disease Control and Prevention released an update on influenza A(H3N2)v transmission and guidelines in the Morbidity and Mortality Weekly Report on December 23, 2011.
The report outlines the development of 12 confirmed cases of human infection with human influenza A(H3N2)v possessing the matrix (M) gene from the influenza A(H1N1)pdm09 virus.
Cases occurred across five States (Indiana, Iowa, Maine, Pennsylvania, and West Virginia) between August 17 and December 23, 2011.
The focus of the report is on the last three of these cases.
The first is an adult male case in Indiana, who had direct contact with swine. He was hospitalized for a period of 4 days and did not receive antiviral treatment before making a full recovery. The report indicates that this highlights the risk of interspecies transmission and details recommendations for swine workers to avoid infection.
The other two cases are children aged <5 years in West Virginia. Both regularly attend the same day-care facility and neither had had recent contact with swine. The first child was already hospitalized for an unrelated condition and was discharged 2 days after the onset of fever while medical care was not sought for the second child. The ten day gap between the onset of their respective illnesses and their lack of exposure to swine was considered by the authors to be strong evidence of limited human-to-human transmission.
Furthermore, the authors recommend that clinicians should consider influenza A(H3N2)v infections in patients who have not had exposure to swine in states where cases have been reported.
The report also contains details of current influenza surveillance of U.S swine. Of 150 isolates sequenced, 30 were A(H3N2) viruses and of these eight possessed the influenza A(H1N1)pdm09 M gene. Further characterization and analysis are ongoing.
Human cases of infection with influenza viruses from swine have been reported on multiple occasions over the last several years. The current series of 12 cases differs from those reported previously in that the genetic material of the virus has recombined with that of the influenza A(H1N1)pdm09 virus, which was responsible for the pandemic of 2009, and acquired the M gene from the pandemic virus.
The M gene has been demonstrated in at least one animal study to be involved in human-to-human transmission and the presence of the M gene from the influenza A(H1N1)pdm09 virus raises this concern.
Indeed, this virus has demonstrated the ability to spread from human-to-human on two occasions and perhaps has had multiple generations of transmission in the current report.
However, so far human-to-human transmission has only occurred with close contact in settings known to facilitate transmission of infectious diseases (i.e. daycare centers and homes) and extensive field investigations have failed to find additional cases in the community.
This virus is similar antigenically and genetically to one circulating in the human population in the mid-1990s implying that individuals born before that time may have partial resistance to infection, which would be consistent with the observation that 11 of the 12 cases have been young children. While three of the 12 cases have been hospitalized, only two were for the acute influenza related illness and all recovered uneventfully.
Notably, all of the 12 viruses tested have been sensitive to oseltamivir.
1. Centers for Disease Control and Prevention. Update: Influenza A(H3N2)v Transmission and Guidelines — Five States, 2011. Morbidity and Mortality Weekly Report, Vol 60, December 23 2011.
2. Centers for Disease Control and Prevention. Swine-Origin Influenza A(H3N2) Virus Infection in Two Children — Indiana and Pennsylvania, July–August 2011. Morbidity and Mortality Weekly Report, Vol 60, Sept. 9, 2011.
3. Chou YY, et al. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J. Virol. doi:10.1128/JVI.05794-11.
4. Lina B, et al. S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill. 2011;16(50):pii=20039. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20039.
Report of a large cluster of oseltamivir resistant viruses in Australia
On December 29, 2011, Australian investigators released a summary account of the characterization of an outbreak with sustained community transmission of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in the state of New South Wales.
The report focuses on 29 oseltamivir-resistant cases identified from 182 patients in the Hunter New England region of the state between May and August 2011. Only one of these 29 patients had received oseltamivir before specimen collection.
Hemagglutinin and neuraminidase analysis showed that resistant strains were closely related, which indicates the spread of a single A(H1N1)pdm09 variant.
An epidemiological link was demonstrated between 10 of the 29 cases. The report describes the significantly higher IC50 values of oseltamivir-resistant viruses to oseltamivir and peramivir compared to wild-type strains but also indicates that oseltamivir-resistant viruses were as susceptible to zanamivir as wild-type strains.
The report also states that the resistant strains are antigenically similar to the vaccine strain including in patients who received the vaccine.
While this outbreak of oseltamivir-resistant influenza viruses raised great concern when first reported, it is notable that since August 2011 no new cases associated with this outbreak have been detected.
Globally, the proportion of viruses with oseltamivir resistance remains about 1% in untreated patients and transmission has been reported only in close settings. Much higher proportions of resistant viruses are detected in some situations such as prolonged treatment in individuals with immunodeficiency.
For the moment, clinicians should continue to use oseltamivir for treatment of high-risk and severe cases of influenza.
However, this event illustrates the need for continued vigilance so that treatment guidelines can be amended when necessary. WHO continues to recommend that countries who have the means to test for oseltamivir-resistant influenza A(H1N1)pdm09 viruses do so in a sample of cases and that all resistant viruses should be sent to a WHO collaborating center for further characterization.
In addition, cases with resistant virus should be investigated for evidence of onward transmission and any findings to suggest that transmission of resistant virus is occurring should be immediately reported to WHO.
Hurt, A.C., et. al. Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza. NEJM, 2011:2541-2542;365(26).
G_MICHIELI (aka IRONOREHOPPER)
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is On
The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.
The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.
Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.
This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.
Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.
Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright
we may be contacted concerning copyright matters at:
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.
For more information please visit:
Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.
FluTrackers Does Not Provide Any Medical Advice:
FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.
These Disclaimers are subject to change at anytime.
Email the Webmaster with questions or comments about this site at firstname.lastname@example.org
All times are GMT -5. The time now is 05:42 AM.